![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
20
Rousselot Sas Boulogne Billancourt Fr, based in France, is a pharmaceutical company.
One of their significant offerings is Gelatin, Acid bone gelatin American origin (American origin), supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2000-026 - Rev 02
This TSE Type CEP, issued on July 01, 2002, remains in force until March 31, 2005, ensuring its reliability within the pharmaceutical industry.
Substance Number 330 associated with this CEP further emphasizes